@FierceMedDev: Evidence is building that MRI scans can be safe for people with pacemakers or implanted defibrillators--via Reuters. Article | Follow @FierceMedDev
@MarkHFierce: TAVI works well for some patients, a new study concludes--a boost for tech made by Edwards, Medtronic and others. Report | Follow @MarkHFierce
@DamianFierce: OmniGuide pulled in $35M from OrbiMed to market its laser surgery devices. More | Follow @DamianFierce
> Pricey medical devices and diagnostic technologies are huge contributors to the increasing cost of inpatient care, according to a study. Article
> China will triple spending on medical devices, drugs, and hospital treatments to nearly $1 trillion by 2020, according to a new McKinsey & Co. report. Story
> BSD Medical ($BSDM) has expanded the MicroThermX microwave ablation system into urban markets across the U.S., hiring new sales reps to expand use of the device. More
> Teleflex ($TFX) scored a three-year deal to put its respiratory devices in Premier healthcare alliance's 2,600 hospitals. News
> Twenty small-scale manufacturers in the state of Gujarat, India, are looking to bolster the local medtech industry by banding together to create a common medical device manufacturing unit, producing raw materials and components they all can use. Report
> Toshiba is boasting that its Aquilion Prime 160 CT scanner has proven effective in imaging patients with irregular heartbeats, something other devices struggle to do accurately. Item
> Nipro Diagnostics has signed a deal to integrate its TRUEresult blood glucose monitoring system with NextGen Healthcare's Ambulatory EHR, allowing users to access blood readings instantly. Story
> AdvaMed is accepting applications for its Medical Technology Veterans Program Boot Camp for Returning Heroes, a year-long initiative aimed to help military veterans find jobs in the medical technology industry. Release
Biotech News
@FierceBiotech: Tech startup waltzes with wireless giant in Africa to expand mobile anti-drug counterfeiting system. Article | Follow @FierceBiotech
@JohnCFierce: ArQule tanks after tox fears force a delay in Asian lung cancer study. News | Follow @JohnCFierce
@RyanMFierce: Achillion M&A talk again post BMS setback with Hep C nuc, but I'm thinking after BMS' M&A debacle pharma won't be so trigger-happy with deals. More | Follow @RyanMFierce
> Hot M&A trend in biopharma spurs surge in insider trading cases. Story
> Strike three: Bad data bury Eli Lilly's late-stage schizophrenia drug. Article
> Boom times for the regulatory affairs profession. Item
> Big Pharma betting billions in high-stakes hunt for the next Lipitor. Report
Pharma News
@FiercePharma: Primary-care sales reps may have a tough time seeing their docs, but cancer reps? Talk to the hand--PharmaTimes. Report | Follow @FiercePharma
> Highly sought GSK plant project runs into local opposition. More
> SEC rounds up insider trading 'ring' around Sanofi's Chattem buyout. News
> FDA panel gives Humira a thumbs-up for colitis. News
Biomarkers News
> Genentech and academics spot colon cancer gene markers. More
> For glioma, it's all in the letters. Story
Drug Delivery News
> Proteonomix licenses out cells that deliver anti-cancer factors. More
> Silence is golden: U.K. RNAi player signs delivery pact with MiReven. Article
> Cisplatin liposomes cut side effects. Item
And Finally... In a TV ad, Mitt Romney says the 2.3% medical device tax rolled into the Affordable Care Act would tax the sale of wheelchairs, but FactCheck.org reports that wheelchairs are in face exempt from the charge. More